Healthcare Pharmaceutical Biotech

Medical Care Technologies Inc. (OTCID:MDCE) Advances Internal Testing of Its AI Wound-Monitoring Application

September 28, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced forward progress on its AI wound-monitoring application, advancing the platform from a development-track mention into structured internal evaluation of sequential wound imaging. The update follows a year in which MDCE has publicly treated wound monitoring as a second health-imaging line beside Melanoma Scan Beta. On July 20, the Company positioned its AI vision platform against the...

Read more

Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides

September 28, 2026 8:45 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that its Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for the Current Bundibugyo Ebolavirus and other Ebola viruses in the Democratic Republic of Congo ("DRC") has started enrolling and dosing patients at an Ebola Treatment Center in the Ituri province. This clinical trial is...

Read more

Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline

September 28, 2026 8:00 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that the contract manufacturing ("CMO") pipeline of its wholly owned subsidiary, Cana Laboratories S.A. ("Cana"), has surpassed $20 million in implied revenue over the life of the underlying agreements, representing over $18 million in implied gross profit at gross margins of over 90%, as the...

Read more

Care Within Reach: How the Bristol Myers Squibb Foundation Is Strengthening Health Systems Across Africa

September 28, 2026 7:29 AM

Francis Kwoba is a 68-year-old retired policeman from Bungoma County, Kenya. During one of his usual morning runs, he experienced a sudden sharp pain in his chest. Concerned by the symptoms, he sought medical attention at the nearest health facility and was prescribed an anti-tuberculosis medication for treatment. After three months, Francis's chest pain persisted and he began experiencing breathlessness. At Moi Teaching and Referral Hospital...

Read more

Global IP Thought Leaders, Scholars, and Policymakers to Gather in Paris for "Competing for the Cure" Conference on Biopharmaceutical Ecosystems

September 28, 2026 7:00 AM

On October 29-30, 2026, the Berkeley Policy Institute's Eira Initiative will host a major international conference titled "Competing for the Cure: Intellectual Property, Innovation Policy, and Biopharmaceutical Ecosystems" at the Maison de l'Amérique Latine in Paris. The two-day event will bring together top economists, legal scholars, industry leaders, and policy architects in the life sciences to present ground-breaking empirical and policy...

Read more

DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application

September 28, 2026 6:00 AM

DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial intelligence platform EinsteinRx™ and smart contracts platform PharmacyChain™, and Tollo Health, LLC ("Tollo"), a healthcare company commercializing proprietary medical foods and dietary supplements and, through TolloBio, developing biopharmaceutical candidates,...

Read more

XVIVO Announces FDA Receipt of PMA Application for The XVIVO Heart Assist Transport System

September 28, 2026 5:20 AM

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - Today, XVIVO announced that the U.S. Food and Drug Administration (FDA) has received the Premarket Approval (PMA) application for the XVIVO Heart Assist Transport System. The application is supported by clinical data from the PRESERVE IDE trial, as well as additional evidence from the PRESERVE Continued Access Protocol (CAP) trial and clinical experience outside the United States. The PRESERVE...

Read more

Hemogenyx Pharmaceuticals PLC Announces Half-year Financial Report

September 28, 2026 2:00 AM

Hemogenyx Pharmaceuticals plc ("Hemogenyx Pharmaceuticals" or the"Company") (LSE:HEMO), the biopharmaceutical group developing therapies designed to transform blood disease treatment, whose shares are admitted to the equity shares (transition) category of the Official List, announces its unaudited interim results for the six-month period ended 30 June 2026. All financial amounts are stated in GBP British pounds unless otherwise indicated. Key...

Read more

MIMS Accelerates Product Innovation and International Growth

September 27, 2026 10:30 PM

MIMS Group, an Asia-Pacific provider of medicines information, clinical decision support, medical communications and marketing services, is accelerating product innovation and international growth as it transforms its long-standing healthcare data, content and market expertise into new technology platforms, customer applications and services. Following the appointment of Sohil Goswami as Group CEO in January 2026, MIMS has reshaped its...

Read more

Bhavitha Guntupalli: Championing Next-Generation Data Integration and Analytics Across Healthcare and Enterprise Landscapes

September 27, 2026 9:05 AM

As healthcare and enterprise organizations increasingly rely on real-time analytics and data-driven decision-making, scalable data integration has become a cornerstone of operational efficiency and digital transformation. Professionals who design reliable, scalable, and efficient data systems play a critical role in enabling these capabilities and supporting business transformation. Driving Enterprise Healthcare Data Integration Bhavitha...

Read more

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026

September 25, 2026 5:00 PM

Integrated BioPharma, Inc. (OTCQX:INBP) (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2026. Revenue for the quarter ended June 30, 2026 was $9.8 million compared to $14.2 million for the quarter ended June 30, 2025, a decrease of $4.4 million or 31.0%. The Company had an operating loss of $0.9 million compared to operating income of approximately $0.6 million in the quarters ended June...

Read more

Innovasis Receives FDA Clearance for Nano-Scale Surface Designation on AxTiHA, TxTiHA, and HAtetracell-C Implants

September 25, 2026 2:20 PM

Innovasis, a privately held developer and manufacturer of spinal implant systems and surgical instrumentation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the nano-scale surface technology used on its AxTiHA Stand-Alone ALIF System, TxTiHA IBF System, and HAtetracell-C Titanium Cervical IBF System implants. The nano-scale hydroxyapatite (HA) surface characterization was reviewed under the FDA's Guidance for...

Read more

NexTel Medical Corp. Showcases Pioneer Exosome Technologies and Diagnostic Innovations at Leading Healthcare Conference

September 25, 2026 1:30 PM

NexTel Medical Corp. (f/k/a Exousia Pro, Inc.) (OTCID:MAJI), a clinical-stage biotechnology company pioneering proprietary exosome-based delivery and diagnostic systems, today announced the successful participation of its executive and medical leadership teams at this week's Orlando Health Conference. Throughout the event, NexTel executives and key scientific advisors engaged directly with industry founders, medical device distributors, and...

Read more

Utah Medical Products, Inc. Clarifies Tender Offer Expiration Date

September 25, 2026 11:00 AM

Utah Medical Products, Inc. (Nasdaq:UTMD) is offering to purchase up to 650,000 shares of its common stock at $75.00 per share. The conditions of the Offer are explained in detail in the SEC Form TO Offer to Purchase and Letter of Transmittal filed with the SEC at https://www.sec.gov/Archives/edgar/data/706698/000109690626001428/0001096906-26-001428-index.html The Offer is scheduled to expire at 5:00 p.m. New York City time, on October 7, unless...

Read more

Kamel Ghribi Hosts ECAM Council in New York, Unveiling Charter on Africa and Calling for Reciprocal Partnerships Over Aid: "Africa Does Not Need Charity; It Needs Partners"

September 25, 2026 10:55 AM

As world leaders gathered in New York, the ECAM Council, hosted by its Chairman Kamel Ghribi at The Plaza Hotel, today presented the ECAM Charter on Africa, a framework built on one core idea: Africa's growth is a defining opportunity for the continent and the world, and it should be pursued through equal partnerships, not charity. "Africa does not need charity; it needs partners," said Ghribi in his opening statement. "Africa is not the...

Read more

A Psychiatrist Got Tired of Watching Patients Burn Out. So He Built an App That Reads the Warning Signs First

September 25, 2026 10:35 AM

After 25 years of psychiatric practice, Dr. Anish Shah noticed a pattern: patients arrived in crisis over problems their bodies had been signaling for weeks. Disrupted sleep. Elevated heart rate. Declining stress resilience. The warning signs were there - but no one was reading them between appointments. Today, Dr. Shah's company Siyan Digital Health announces CuraTrail - an AI-powered wellness app that changes that equation. CuraTrail connects...

Read more

Vicapsys Life Sciences Announces Advisory Board Following Completion of Stateline Merger

September 25, 2026 10:05 AM

Vicapsys Life Sciences, Inc. (OTC PINK:VICP) ("VICP" or the "Company") today announced the members of its Advisory Board, formed following the completion of the Company's reverse merger with Stateline Distributors of Puerto Rico, Inc. ("Stateline") on September 3, 2026. The Advisory Board provides guidance to the Company's management on strategy, operations and market access. Members of the Advisory Board serve in an advisory capacity and are...

Read more

Aesthetic Surgery Center Wins First Place in Two Categories in the 2026 Best of Naples Community's Choice Awards

September 25, 2026 9:00 AM

Aesthetic Surgery Center has received first place in two categories of the 2026 Best of Naples Community's Choice Awards, the annual program presented by the Naples Daily News and decided by public vote. The practice was voted Best Cosmetic/Plastic Surgery Center, and its owner and medical director, Dr. Anurag Agarwal, was voted Best Plastic Surgeon. The 2026 first place results are: Best Cosmetic/Plastic Surgery Center: Aesthetic Surgery Center...

Read more

CVS Health Strengthens Energy Resilience To Support Patient Care

September 25, 2026 8:45 AM

CVS Health Originally published on CVS Health Company Newsroom The demand for reliable energy continues to grow, and for CVS Health, dependable operations are essential to serving millions of patients and customers across the country. That's why we're expanding our use of renewable electricity and investing in energy solutions that help reduce emissions, strengthen business resilience and support uninterrupted care. These efforts are part of our...

Read more

Innovative Kidney Care in Kenya: Bena Care's Journey of Hope, Resilience, and Partnerships

September 25, 2026 8:35 AM

Boehringer Ingelheim In 2017, I was a young student nurse in Kenya, grappling with the stark realities of our national healthcare system. I saw families drained financially and emotionally by long-term hospital stays for their loved ones. The pain was not just in the illness but in the struggle for dignity and care. This is where Bena Care began-from a deep conviction that healthcare could be more compassionate, more accessible. A perspective by...

Read more